An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Laura A. VanBlargan(Washington University in St. Louis), John M. Errico(Washington University in St. Louis), Peter Halfmann(University of Wisconsin–Madison), Seth J. Zost(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Lisa A. Purcell(VIR Biotechnology (United States)), Yoshihiro Kawaoka(University of Wisconsin–Madison), Davide Corti(Vir Biotechnology (Switzerland)), Daved H. Fremont(Washington University in St. Louis), Michael Diamond(St. Andrews University)
Nature Medicine
January 19, 2022
10.1038/s41591-021-01678-y
Cited by 764Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis